Kali Mur

Kali Mur is an FDA drug label for the active ingredient KALI MURIATICUM manufactured by Energique, Inc. administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20230104.

Generic: KALI MURIATICUM

Manufacturer: Energique, Inc.

Product Type: HUMAN OTC DRUG

Route: ORAL

Dosage Form:

NDC: 44911-0166

Application:

Effective: 20230104

Active Ingredients: ACTIVE INGREDIENT: (in each drop) Kali Muriaticum 200C 100%.

Indications & Usage

USES: May temporarily relieve nasal congestion and chronic ear complaints.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Dosage & Administration

DIRECTIONS: • Adults and children 5 to 10 drops orally, 1 time daily or as otherwise directed by a health care professional. • Consult a physician for use in children under 12 years of age.

Contraindications

Not available.

Warnings

WARNINGS: Stop use and ask a doctor if symptoms persist for more than 4 days. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. DO NOT USE IF TAMPER EVIDENT SEAL IS BROKEN OR MISSING Store in a cool, dry place.

Adverse Reactions